New Molex Campus in Poland to Support Medical Device Delivery

2023-11-16
Phillips-Medisize, a Molex company, will be able to provide its pharmaceutical and medtech customers with new capabilities and support through an expanded European footprint.
Molex has opened a new campus in Katowice, Poland. The facility's initial 23,000 square-meter manufacturing space is intended to serve as a strategic central location to help facilitate timely delivery of advanced medical devices for Phillips-Medisize, as well as electric vehicle and electrification solutions for Molex customers. Future expansion of up to 85,000 square meters is built into the company's growth plans for the facility.
So far, Molex has invested $110 million in these facilities that will initially support Phillips-Medisize with production of pharmaceutical, medical and diagnostic devices. The site capabilities will include advanced medical device assembly, packaging, drug handling, and injection molding.
Image courtesy of Molex
New Molex Campus in Poland to Support Medical Device Delivery
Preview
来源: mddionline
The Katowice campus will complement Phillips-Medisize's existing operations at six European manufacturing sites in Ireland, Denmark, Czech Republic, and two locations in Kontiolahti, Finland.
The large pool of skilled manufacturing and engineering resources in the Katowice area was a major factor influencing Molex's selection of the site location, the company noted. At planned capacity, the first facilities within the campus will employ about 350 employees, including highly skilled production operators, design engineers, and quality specialists.
Combining high technology expertise and skilled labor means that both Phillips-Medisize medical customers and Molex automotive and electrification customers now have access to the company's expert capabilities, high-quality services and support in a location that enables speed-to-market and superior quality in product delivery.
The campus will be the first site for both Molex and Phillips-Medisize to hold a LEED Gold certification. ISO 13485 certification is pending construction completion, with additional certifications and registrations to follow, offering more localized value to those customers who require this exacting manufacturing quality.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。